Protein O-linked mannose β1,2-N-acetylglucosaminyltransferase 1 (POMGNT1) is a Golgi glycosyltransferase that catalyzes the formation of the N-acetylglucosamine (GlcNAc) β1→2Man linkage of O-mannosyl glycan. POMGNT1 is not modified by N-glycans because there are no potential N-glycosylation sites; however, it is not clear whether POMGNT1 is modified by O-glycans. To determine whether POMGNT1 is O-glycosylated, we prepared recombinant human POMGNT1 from HEK293T cells. The recombinant POMGNT1 was recognized by Sambucus sieboldiana lectin (SSA), and sialidase digestion of POMGNT1 decreased SSA reactivity and enhanced the reactivity of Arachis hypogaea lectin (PNA). These results suggest that POMGNT1 is modified by a sialylated core-1 O-glycan. Next, we analyzed the structures of the O-glycans on POMGNT1 by β-elimination and pyrazolone-labeling methods in combination with mass spectrometry. We identified several mucin-type O-glycans containing (NeuAc) 1 (Hex) 1 (HexNAc) 1 , (NeuAc) 2 (Hex) 1 (HexNAc) 1 , and (NeuAc) 2 (Hex) 2 (HexNAc) 2 . To examine whether the O-glycans affect the functions and properties of POMGNT1, we compared glycosylated and non-glycosylated forms of recombinant sPOMGNT1 for their activity and surface hydrophobicity using the hydrophobic probe 1-anilino-8-naphthalene sulfonate (ANS). POMGNT1 activity and surface hydrophobicity were not affected by the presence or absence of O-glycans.
Key words O-glycosylation; mucin-typeProtein O-linked mannose β1,2-N-acetylglucosaminyltransferase 1 (POMGNT1) catalyzes the formation of the N-acetylglucosamine (GlcNAc) β1 2Man linkage by transferring GlcNAc from a uridine 5′-diphosphate (UDP)-GlcNAc to an O-mannose of glycoproteins.1,2) POMGNT1 is a typical type II membrane protein and is localized in the Golgi apparatus.3) Human POMGNT1 is composed of 660 amino acids and the following four domains: an N-terminal cytoplasmic tail, a transmembrane domain, a stem domain, and a catalytic domain 4) (Fig. 1A). The gene encoding POMGNT1 is responsible for muscle-eye-brain disease (MEB), 1) which is a type of α-dystroglycanopathy and an autosomal recessive disorder characterized by congenital muscular dystrophy with neuronal migration disorder.2) All known mutations in the POMGNT1 gene in MEB patients cause a loss of enzyme activity, indicating that loss-of-function of the POMGNT1 gene induces defective O-mannosylation.1,5) More recently, a selective deficiency in glycosylated α-dystroglycan (α-DG) in MEB patients has been found, suggesting that hypoglycosylation of α-DG may be the pathomechanism of MEB.2) In spite of the progress in identifying the disease-causing gene (POMGNT1) and understanding its pathomechanism, effective therapies for MEB have not yet been established. There are several therapeutic strategies, for example, gene replacement therapy and enzyme supplement therapy. For the latter strategy, it is important to characterize the properties of the POMGNT1 protein in detail.Protein glycosylation is a major post-translational modification.6) The major glyc...